Overview
- 1 public-safe observation is available for this inspection.
- 1 structured CFR citation is represented.
- 3 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
19 Oct 2012
21 CFR 211.113(b)
Procedures for sterile drug products
Cited by Stephen D Brown, David J Gomes, Pal S Mayasandra
Inspected site
SBSmithKline Beecham LimitedWorthing, United Kingdom
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 1 observation
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere